MOGRAA Trademark

Trademark Overview


On Monday, August 29, 2016, a trademark application was filed for MOGRAA with the United States Patent and Trademark Office. The USPTO has given the MOGRAA trademark a serial number of 79198394. The federal status of this trademark filing is PARTIAL SECTION 71 & 15 ACCEPTED AND ACKNOWLEDGED as of Monday, August 21, 2023. This trademark is owned by NB HEALTH LABORATORY CO. LTD.. The MOGRAA trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

[ Pharmaceutical preparations for modification of the function of g-protein-coupled receptors, consisting of monoclonal antibody; pharmaceutical preparations for the treatment and prevention of obesity, diabetes, cardiovascular diseases, central nervous system diseases, metabolic disorders, stroke, cancer, inflammatory diseases, respiratory diseases, infectious diseases, auto-immune diseases and pain; antibodies for medical purposes; reagent paper for medical purposes ]

Scientific research; research and development services in the field of antibodies; research and development for the pharmaceutical industry; chemistry services; testing, inspection or research of pharmaceuticals, cosmetics or foodstuffs [ ; design and development of computer software; consultancy relating to design and development of computer software; computer software design, computer programming, or maintenance of computer software ]
mograa

General Information


Serial Number79198394
Word MarkMOGRAA
Filing DateMonday, August 29, 2016
Status708 - PARTIAL SECTION 71 & 15 ACCEPTED AND ACKNOWLEDGED
Status DateMonday, August 21, 2023
Registration Number5188911
Registration DateTuesday, April 25, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 7, 2017

Trademark Statements


Goods and Services[ Pharmaceutical preparations for modification of the function of g-protein-coupled receptors, consisting of monoclonal antibody; pharmaceutical preparations for the treatment and prevention of obesity, diabetes, cardiovascular diseases, central nervous system diseases, metabolic disorders, stroke, cancer, inflammatory diseases, respiratory diseases, infectious diseases, auto-immune diseases and pain; antibodies for medical purposes; reagent paper for medical purposes ]
Goods and ServicesScientific research; research and development services in the field of antibodies; research and development for the pharmaceutical industry; chemistry services; testing, inspection or research of pharmaceuticals, cosmetics or foodstuffs [ ; design and development of computer software; consultancy relating to design and development of computer software; computer software design, computer programming, or maintenance of computer software ]

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status CodeG - NOT AVAILABLE
Class Status DateMonday, August 21, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, December 22, 2016
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNB HEALTH LABORATORY CO. LTD.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressJP

Party NameNB HEALTH LABORATORY CO. LTD.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressJP

Party NameNB HEALTH LABORATORY CO. LTD.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJP

Trademark Events


Event DateEvent Description
Friday, December 30, 2016CORRECTION TRANSACTION RECEIVED FROM IB
Thursday, December 15, 2016SN ASSIGNED FOR SECT 66A APPL FROM IB
Wednesday, December 21, 2016LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, December 22, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 22, 2016ASSIGNED TO EXAMINER
Tuesday, December 27, 2016APPLICATION FILING RECEIPT MAILED
Wednesday, December 28, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 18, 2017NOTICE OF PUBLICATION
Tuesday, February 7, 2017PUBLISHED FOR OPPOSITION
Tuesday, February 14, 2017CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
Tuesday, April 25, 2017REGISTERED-PRINCIPAL REGISTER
Thursday, May 25, 2017GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Wednesday, June 14, 2017FINAL DISPOSITION PROCESSED
Wednesday, June 14, 2017FINAL DISPOSITION NOTICE SENT TO IB
Friday, August 4, 2017NOTIFICATION PROCESSED BY IB
Friday, January 27, 2023TEAS SECTION 71 & 15 RECEIVED
Tuesday, August 15, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, August 21, 2023REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
Monday, August 21, 2023NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Wednesday, May 1, 2024INVALIDATION PROCESSED
Sunday, April 21, 2024PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Wednesday, May 1, 2024PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Friday, February 28, 2025NEW REPRESENTATIVE AT IB RECEIVED
Monday, May 27, 2024PARTIAL INVALIDATION PROCESSED BY THE IB